Fundraising FoxSB TEMPUS
Tokyo, JP · 1 known investors
Find your way into SB TEMPUS
Each arrow is one introduction. Sign up to fill in the first one.
260 people can intro you to Ryan
Ask Joe Hayes to introduce you to Ryan Fukushima
You →Joe · together at Pathos →Ryan
Sign up to find every way you can get introduced to SB TEMPUS
- Your email: who you already know at SB TEMPUS, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SB TEMPUS team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.
Founders & leadership
柴和
柴山 和久Director, CTO
松健
松井 健太郎Representative Director, President and CEO
RF
Ryan FukushimaRepresentative DirectorRyan Fukushima was the first employee at Tempus AI and contributed to scaling the company through its IPO, later leading the Data & Apps division. He is also cofounder and former CEO of Pathos AI, which focuses on applying AI to drug development and precision oncology.
筒多
筒井 多圭志Director, Chief Scientist
Board
AP
Andy PolovinBoard director
JR
Jim RogersBoard director
Investors · 1
Frequently asked questions
- What does SB TEMPUS do?
- SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.
- Who are SB TEMPUS's investors?
- SB TEMPUS's investors include SoftBank Group.
- Where is SB TEMPUS headquartered?
- SB TEMPUS is headquartered in Tokyo, JP.